Adagene Inc

Industry · 7 registered clinical trials — 1 currently recruiting.

Status	Trial	Phase	Started
Active Not Recruiting	Study of ADG206 in Subjects With Advanced/Metastatic Solid Tumors Advanced/Metastatic Solid Tumors	Phase 1	2023-02-13
Recruiting	ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors Advanced/Metastatic Solid Tumors	Phase 1 / Phase 2	2022-06-15
Completed	ADG116 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors Advanced/Metastatic Solid Tumors	Phase 1	2022-02-09
Completed	ADG126, ADG126 in Combination With Anti PD1 Antibody, and ADG126 in Combination With ADG106 in Advanced/Metast Advanced/Metastatic Solid Tumors	Phase 1 / Phase 2	2021-03-15
Completed	A Phase 1b/2 Study of ADG116, ADG116 Combined With Anti-PD-1 Antibody or Anti-CD137 Antibody in Solid Tumors P Advanced/Metastatic Solid Tumors	Phase 1	2020-09-23
Terminated	Study of ADG116 in Patients With Advanced/Metastatic Solid Tumors Solid Tumor	Phase 1	2019-08-29
Completed	Study of CD137 Agonist ADG106 With Advanced or Metastatic Solid Tumors and/or Non-Hodgkin Lymphoma Solid Tumors, Non-Hodgkin Lymphoma	Phase 1	2018-09-17